{"id":"https://openalex.org/W2019907646","doi":"https://doi.org/10.5551/jat.13.295","title":"Influence of 3-hydroxy-3-methylglutaryl Coenzyme A Reductase Inhibitors on Ubiquinone Levels in Rat Skeletal Muscle and Heart: Relationship to Cytotoxicity and Inhibitory Activity for Cholesterol Synthesis in Human Skeletal Muscle Cells","display_name":"Influence of 3-hydroxy-3-methylglutaryl Coenzyme A Reductase Inhibitors on Ubiquinone Levels in Rat Skeletal Muscle and Heart: Relationship to Cytotoxicity and Inhibitory Activity for Cholesterol Synthesis in Human Skeletal Muscle Cells","publication_year":2006,"publication_date":"2006-01-01","ids":{"openalex":"https://openalex.org/W2019907646","doi":"https://doi.org/10.5551/jat.13.295","mag":"2019907646","pmid":"https://pubmed.ncbi.nlm.nih.gov/17192694"},"language":"en","primary_location":{"id":"doi:10.5551/jat.13.295","doi":"https://doi.org/10.5551/jat.13.295","is_oa":true,"landing_page_url":"https://doi.org/10.5551/jat.13.295","pdf_url":"https://www.jstage.jst.go.jp/article/jat/13/6/13_6_295/_pdf","source":{"id":"https://openalex.org/S140063188","display_name":"Journal of Atherosclerosis and Thrombosis","issn_l":"1340-3478","issn":["1340-3478","1880-3873"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","jufo-1","medline","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310313348","host_organization_name":"Japan Atherosclerosis Society","host_organization_lineage":["https://openalex.org/P4310313348"],"host_organization_lineage_names":["Japan Atherosclerosis Society"],"type":"journal"},"license":"cc-by-nc-sa","license_id":"https://openalex.org/licenses/cc-by-nc-sa","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Atherosclerosis and Thrombosis","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://www.jstage.jst.go.jp/article/jat/13/6/13_6_295/_pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5019349961","display_name":"Hiroyuki Yamazaki","orcid":"https://orcid.org/0000-0002-5633-8997","observed_orcids":["https://orcid.org/0000-0002-5633-8997"]},"institutions":[{"id":"https://openalex.org/I4210088742","display_name":"Kowa (Japan)","ror":"https://ror.org/009z2z347","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210088742"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Hiroyuki Yamazaki","raw_affiliation_strings":["Tokyo New Drug Research Laboratories I, Pharmaceutical Division, Kowa, Co. Ltd","Tokyo New Drug Research Laboratories I, Pharmaceutical Division, Kowa, Co. Ltd, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Tokyo New Drug Research Laboratories I, Pharmaceutical Division, Kowa, Co. Ltd","institution_ids":["https://openalex.org/I4210088742"]},{"raw_affiliation_string":"Tokyo New Drug Research Laboratories I, Pharmaceutical Division, Kowa, Co. Ltd, Japan","institution_ids":["https://openalex.org/I4210088742"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005180396","display_name":"Mahomi Suzuki","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210088742","display_name":"Kowa (Japan)","ror":"https://ror.org/009z2z347","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210088742"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Mahomi Suzuki","raw_affiliation_strings":["Tokyo New Drug Research Laboratories I, Pharmaceutical Division, Kowa, Co. Ltd"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Tokyo New Drug Research Laboratories I, Pharmaceutical Division, Kowa, Co. Ltd","institution_ids":["https://openalex.org/I4210088742"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Taro Aoki","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210088742","display_name":"Kowa (Japan)","ror":"https://ror.org/009z2z347","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210088742"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Taro Aoki","raw_affiliation_strings":["Tokyo New Drug Research Laboratories I, Pharmaceutical Division, Kowa, Co. Ltd"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Tokyo New Drug Research Laboratories I, Pharmaceutical Division, Kowa, Co. Ltd","institution_ids":["https://openalex.org/I4210088742"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035518142","display_name":"Shigeru Morikawa","orcid":"https://orcid.org/0000-0001-6249-6716","observed_orcids":["https://orcid.org/0000-0001-6249-6716"]},"institutions":[{"id":"https://openalex.org/I4210088742","display_name":"Kowa (Japan)","ror":"https://ror.org/009z2z347","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210088742"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Shigeru Morikawa","raw_affiliation_strings":["Tokyo New Drug Research Laboratories I, Pharmaceutical Division, Kowa, Co. Ltd"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Tokyo New Drug Research Laboratories I, Pharmaceutical Division, Kowa, Co. Ltd","institution_ids":["https://openalex.org/I4210088742"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Takashi Maejima","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210088742","display_name":"Kowa (Japan)","ror":"https://ror.org/009z2z347","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210088742"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Takashi Maejima","raw_affiliation_strings":["Tokyo New Drug Research Laboratories I, Pharmaceutical Division, Kowa, Co. Ltd"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Tokyo New Drug Research Laboratories I, Pharmaceutical Division, Kowa, Co. Ltd","institution_ids":["https://openalex.org/I4210088742"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110007515","display_name":"Fumiyasu Sato","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210088742","display_name":"Kowa (Japan)","ror":"https://ror.org/009z2z347","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210088742"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Fumiyasu Sato","raw_affiliation_strings":["Tokyo New Drug Research Laboratories I, Pharmaceutical Division, Kowa, Co. Ltd"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Tokyo New Drug Research Laboratories I, Pharmaceutical Division, Kowa, Co. Ltd","institution_ids":["https://openalex.org/I4210088742"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027637294","display_name":"Kimio Sawanobori","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210088742","display_name":"Kowa (Japan)","ror":"https://ror.org/009z2z347","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210088742"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Kimio Sawanobori","raw_affiliation_strings":["Tokyo New Drug Research Laboratories I, Pharmaceutical Division, Kowa, Co. Ltd"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Tokyo New Drug Research Laboratories I, Pharmaceutical Division, Kowa, Co. Ltd","institution_ids":["https://openalex.org/I4210088742"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108585738","display_name":"Masaki Kitahara","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210112703","display_name":"Nissan Chemical Corporation (Japan)","ror":"https://ror.org/01skwyh03","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210112703"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Masaki Kitahara","raw_affiliation_strings":["Shiraoka Research Station of Biological Science, Nissan Chemical Industries, Ltd., Shiraoka"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Shiraoka Research Station of Biological Science, Nissan Chemical Industries, Ltd., Shiraoka","institution_ids":["https://openalex.org/I4210112703"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5107007603","display_name":"Tatsuhiko Kodama","orcid":"https://orcid.org/0000-0003-3747-7956","observed_orcids":["https://orcid.org/0000-0003-3747-7956"]},"institutions":[{"id":"https://openalex.org/I74801974","display_name":"The University of Tokyo","ror":"https://ror.org/057zh3y96","country_code":"JP","type":"education","lineage":["https://openalex.org/I74801974"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Tatsuhiko Kodama","raw_affiliation_strings":["Laboratory for System Biology and Medicine, RCAST, The University of Tokyo"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratory for System Biology and Medicine, RCAST, The University of Tokyo","institution_ids":["https://openalex.org/I74801974"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5103484910","display_name":"Yasushi Sait\u014d","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I159385669","display_name":"Chiba University","ror":"https://ror.org/01hjzeq58","country_code":"JP","type":"education","lineage":["https://openalex.org/I159385669"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Yasushi Saito","raw_affiliation_strings":["Department of Clinical Cell Biology (F5), Graduate School of Medicine, Chiba University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Cell Biology (F5), Graduate School of Medicine, Chiba University","institution_ids":["https://openalex.org/I159385669"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.786,"has_fulltext":true,"cited_by_count":25,"citation_normalized_percentile":{"value":0.64450955,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":"13","issue":"6","first_page":"295","last_page":"307"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T13012","display_name":"Coenzyme Q10 studies and effects","score":0.9901999831199646,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T13012","display_name":"Coenzyme Q10 studies and effects","score":0.9901999831199646,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10394","display_name":"Lipoproteins and Cardiovascular Health","score":0.005799999926239252,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12465","display_name":"Cancer, Lipids, and Metabolism","score":0.0013000000035390258,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/statins","display_name":"statins","score":0.9860000014305115},{"id":"https://openalex.org/keywords/coenzyme-q10","display_name":"coenzyme Q10","score":0.9430000185966492},{"id":"https://openalex.org/keywords/cerivastatin","display_name":"cerivastatin","score":0.8669999837875366},{"id":"https://openalex.org/keywords/pitavastatin","display_name":"pitavastatin","score":0.996999979019165},{"id":"https://openalex.org/keywords/fluvastatin","display_name":"fluvastatin","score":0.7319999933242798},{"id":"https://openalex.org/keywords/simvastatin","display_name":"simvastatin","score":0.996999979019165},{"id":"https://openalex.org/keywords/atorvastatin","display_name":"atorvastatin","score":0.9980000257492065},{"id":"https://openalex.org/keywords/pravastatin","display_name":"pravastatin","score":0.9990000128746033},{"id":"https://openalex.org/keywords/skeletal-muscle-cells","display_name":"skeletal muscle cells","score":0.7620000243186951},{"id":"https://openalex.org/keywords/cardiotoxicity","display_name":"cardiotoxicity","score":0.7210000157356262},{"id":"https://openalex.org/keywords/myopathy","display_name":"myopathy","score":0.7990000247955322},{"id":"https://openalex.org/keywords/cholesterol-synthesis-inhibition","display_name":"cholesterol synthesis inhibition","score":0.7639999985694885},{"id":"https://openalex.org/keywords/rat-heart","display_name":"rat heart","score":0.4749999940395355},{"id":"https://openalex.org/keywords/rat-skeletal-muscle","display_name":"rat skeletal muscle","score":0.7710000276565552}],"concepts":[{"id":"https://openalex.org/C2779415389","wikidata":"https://www.wikidata.org/wiki/Q423439","display_name":"Cerivastatin","level":4,"score":0.9956756830215454},{"id":"https://openalex.org/C2776692505","wikidata":"https://www.wikidata.org/wiki/Q412677","display_name":"Pitavastatin","level":3,"score":0.8521666526794434},{"id":"https://openalex.org/C2779519902","wikidata":"https://www.wikidata.org/wiki/Q1240093","display_name":"Pravastatin","level":3,"score":0.7776501178741455},{"id":"https://openalex.org/C2779959927","wikidata":"https://www.wikidata.org/wiki/Q1048687","display_name":"Skeletal muscle","level":2,"score":0.6915549039840698},{"id":"https://openalex.org/C2776839432","wikidata":"https://www.wikidata.org/wiki/Q954845","display_name":"Statin","level":2,"score":0.6875792145729065},{"id":"https://openalex.org/C2777482532","wikidata":"https://www.wikidata.org/wiki/Q668093","display_name":"Atorvastatin","level":2,"score":0.6548981666564941},{"id":"https://openalex.org/C2776329913","wikidata":"https://www.wikidata.org/wiki/Q670131","display_name":"Simvastatin","level":2,"score":0.6520170569419861},{"id":"https://openalex.org/C2778417548","wikidata":"https://www.wikidata.org/wiki/Q417942","display_name":"Fluvastatin","level":3,"score":0.6077768206596375},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.566170334815979},{"id":"https://openalex.org/C134651460","wikidata":"https://www.wikidata.org/wiki/Q3100717","display_name":"Reductase","level":3,"score":0.5289853811264038},{"id":"https://openalex.org/C104950815","wikidata":"https://www.wikidata.org/wiki/Q415607","display_name":"HMG-CoA reductase","level":4,"score":0.5268515348434448},{"id":"https://openalex.org/C109316439","wikidata":"https://www.wikidata.org/wiki/Q246181","display_name":"Cytotoxicity","level":3,"score":0.48028942942619324},{"id":"https://openalex.org/C2777300911","wikidata":"https://www.wikidata.org/wiki/Q692536","display_name":"Myopathy","level":2,"score":0.47424548864364624},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.4611426293849945},{"id":"https://openalex.org/C2778163477","wikidata":"https://www.wikidata.org/wiki/Q43656","display_name":"Cholesterol","level":2,"score":0.4517362713813782},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4385809004306793},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.4201948046684265},{"id":"https://openalex.org/C2780940807","wikidata":"https://www.wikidata.org/wiki/Q417740","display_name":"Lovastatin","level":3,"score":0.4147696793079376},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3859196603298187},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.25132638216018677},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.15036332607269287},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.05865508317947388}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002470","descriptor_name":"Cell Survival","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D002478","descriptor_name":"Cells, Cultured","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002784","descriptor_name":"Cholesterol","qualifier_ui":"Q000096","qualifier_name":"biosynthesis","is_major_topic":true},{"descriptor_ui":"D002784","descriptor_name":"Cholesterol","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D004798","descriptor_name":"Enzymes","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D004798","descriptor_name":"Enzymes","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D006321","descriptor_name":"Heart","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008055","descriptor_name":"Lipids","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009124","descriptor_name":"Muscle Proteins","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D009124","descriptor_name":"Muscle Proteins","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D009206","descriptor_name":"Myocardium","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D014451","descriptor_name":"Ubiquinone","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D017208","descriptor_name":"Rats, Wistar","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018482","descriptor_name":"Muscle, Skeletal","qualifier_ui":"Q000166","qualifier_name":"cytology","is_major_topic":false},{"descriptor_ui":"D018482","descriptor_name":"Muscle, Skeletal","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D018482","descriptor_name":"Muscle, Skeletal","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D019161","descriptor_name":"Hydroxymethylglutaryl-CoA Reductase Inhibitors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.5551/jat.13.295","doi":"https://doi.org/10.5551/jat.13.295","is_oa":true,"landing_page_url":"https://doi.org/10.5551/jat.13.295","pdf_url":"https://www.jstage.jst.go.jp/article/jat/13/6/13_6_295/_pdf","source":{"id":"https://openalex.org/S140063188","display_name":"Journal of Atherosclerosis and Thrombosis","issn_l":"1340-3478","issn":["1340-3478","1880-3873"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","jufo-1","medline","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310313348","host_organization_name":"Japan Atherosclerosis Society","host_organization_lineage":["https://openalex.org/P4310313348"],"host_organization_lineage_names":["Japan Atherosclerosis Society"],"type":"journal"},"license":"cc-by-nc-sa","license_id":"https://openalex.org/licenses/cc-by-nc-sa","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Atherosclerosis and Thrombosis","raw_type":"journal-article"},{"id":"pmid:17192694","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/17192694","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of atherosclerosis and thrombosis","raw_type":"Comparative Study"}],"best_oa_location":{"id":"doi:10.5551/jat.13.295","doi":"https://doi.org/10.5551/jat.13.295","is_oa":true,"landing_page_url":"https://doi.org/10.5551/jat.13.295","pdf_url":"https://www.jstage.jst.go.jp/article/jat/13/6/13_6_295/_pdf","source":{"id":"https://openalex.org/S140063188","display_name":"Journal of Atherosclerosis and Thrombosis","issn_l":"1340-3478","issn":["1340-3478","1880-3873"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","jufo-1","medline","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310313348","host_organization_name":"Japan Atherosclerosis Society","host_organization_lineage":["https://openalex.org/P4310313348"],"host_organization_lineage_names":["Japan Atherosclerosis Society"],"type":"journal"},"license":"cc-by-nc-sa","license_id":"https://openalex.org/licenses/cc-by-nc-sa","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Atherosclerosis and Thrombosis","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.9922999739646912,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2019907646.pdf","grobid_xml":"https://content.openalex.org/works/W2019907646.grobid-xml"},"referenced_works_count":47,"referenced_works":["https://openalex.org/W233923097","https://openalex.org/W1531306901","https://openalex.org/W1554154613","https://openalex.org/W1606937999","https://openalex.org/W1837763605","https://openalex.org/W1881846348","https://openalex.org/W1963829759","https://openalex.org/W1969449194","https://openalex.org/W1986680773","https://openalex.org/W1988188106","https://openalex.org/W1995622255","https://openalex.org/W1999893825","https://openalex.org/W2001941727","https://openalex.org/W2003307830","https://openalex.org/W2005786831","https://openalex.org/W2010028742","https://openalex.org/W2011659815","https://openalex.org/W2015814654","https://openalex.org/W2020277276","https://openalex.org/W2024135550","https://openalex.org/W2032099385","https://openalex.org/W2036015501","https://openalex.org/W2037465679","https://openalex.org/W2040939339","https://openalex.org/W2059078444","https://openalex.org/W2059930169","https://openalex.org/W2061393221","https://openalex.org/W2062783439","https://openalex.org/W2074541010","https://openalex.org/W2076907924","https://openalex.org/W2078603028","https://openalex.org/W2078883566","https://openalex.org/W2091243061","https://openalex.org/W2100233089","https://openalex.org/W2103403311","https://openalex.org/W2114918609","https://openalex.org/W2120649473","https://openalex.org/W2125149319","https://openalex.org/W2136137463","https://openalex.org/W2145512527","https://openalex.org/W2155598961","https://openalex.org/W2183663567","https://openalex.org/W2192767584","https://openalex.org/W2949155240","https://openalex.org/W4245512005","https://openalex.org/W4246764494","https://openalex.org/W4249556169"],"related_works":["https://openalex.org/W2062783439","https://openalex.org/W2024554929","https://openalex.org/W2169787431","https://openalex.org/W2061393221","https://openalex.org/W2074995333","https://openalex.org/W2045911575","https://openalex.org/W2095119347","https://openalex.org/W1501300822","https://openalex.org/W2138070400","https://openalex.org/W2002886895"],"abstract_inverted_index":{"Although":[0],"statins":[1,29,52,96],"are":[2],"prescribed":[3],"as":[4],"relatively":[5],"safe":[6],"and":[7,47,58,67,78,142,185],"effective":[8,172],"drugs":[9],"for":[10],"hypercholesterolemic":[11],"patients,":[12],"it":[13,151],"has":[14,39],"been":[15,40],"reported":[16],"that":[17,154,176],"a":[18,106],"significant":[19],"side":[20],"effect,":[21],"myopathy,":[22],"occurs":[23],"infrequently":[24],"during":[25],"medication.":[26],"Moreover,":[27],"because":[28],"decrease":[30],"cardiac":[31,37],"ubiquinone":[32,71,117,126,157,188],"levels,":[33],"the":[34,49,68,81,89,95,99,102,129,132,160,171,179,191],"risk":[35],"of":[36,51,85,101,134],"dysfunction":[38],"suggested.":[41],"This":[42],"study":[43],"sought":[44],"to":[45],"evaluate":[46],"compare":[48],"cytotoxicity":[50,91,182],"(cerivastatin,":[53],"pitavastatin,":[54,168],"fluvastatin,":[55],"simvastatin,":[56],"atorvastatin":[57],"pravastatin)":[59],"in":[60,73,105,119,128,159,183,190],"cultured":[61],"human":[62],"skeletal":[63,76,120],"muscle":[64,77],"cells":[65],"(HSkMCs)":[66],"effects":[69,100],"on":[70,170],"levels":[72,118,127,158,189],"statin-treated":[74],"rat":[75,110,161,192],"heart.":[79,130,193],"Cerivastatin,":[80],"most":[82,180],"potent":[83,181],"inhibitor":[84],"HMG-CoA":[86],"reductase,":[87],"showed":[88,178],"strongest":[90],"(over":[92],"10-fold)":[93],"among":[94],"examined,":[97],"while":[98],"others":[103],"were":[104,148],"similar":[107],"range.":[108],"In":[109],"experiments,":[111],"neither":[112],"pitavastatin":[113,137],"nor":[114],"cerivastatin":[115,143,155,177],"decreased":[116],"muscle,":[121],"but":[122],"both":[123],"dose-dependently":[124],"lowered":[125,187],"As":[131],"rates":[133],"reduction":[135],"by":[136],"(9.6%":[138],"at":[139,145],"30":[140],"mg/kg)":[141,147],"(9.7%":[144],"0.3":[146],"almost":[149],"equal,":[150],"was":[152],"estimated":[153],"reduced":[156],"heart":[162],"approximately":[163],"100-fold":[164],"more":[165],"strongly":[166,186],"than":[167],"based":[169],"doses.":[173],"We":[174],"found":[175],"HSkMCs":[184]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2020,"cited_by_count":2},{"year":2018,"cited_by_count":2},{"year":2016,"cited_by_count":1},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":3},{"year":2012,"cited_by_count":2}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}